It has been shown that deregulated BCR signaling is a driving mechanism for CLL development, progression, and relapse, as there is an increase BCR signaling activity in CLL cells compared to healthy B cells [28]. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.